Authors:
Varotto, F
Di Maria, G
Azzaro, R
Bellissima, P
Amato, R
Fogliani, V
Muscianisi, G
Sabato, V
Girbino, G
Ando, F
Lagana, P
Delia, S
Jacoviello, C
Maierna, G
Pezza, A
Covelli, I
Magri, M
Napoletano, G
Rossi, A
Marone, P
Sanguinetti, C
Pela, R
Tedeschi, D
Viola, B
Cicciarella, S
Messina, G
Rizza, S
Fraschini, F
Citation: F. Varotto et al., An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: Piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone, J CHEMOTHER, 13(4), 2001, pp. 413-423
Authors:
Mor, M
Spadoni, G
Di Giacomo, B
Diamantini, G
Bedini, A
Tarzia, G
Plazzi, PV
Rivara, S
Nonno, R
Lucini, V
Pannacci, M
Fraschini, F
Stankov, BM
Citation: M. Mor et al., Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands, BIO MED CH, 9(4), 2001, pp. 1045-1057
Authors:
Spadoni, G
Balsamini, C
Diamantini, G
Tontini, A
Tarzia, G
Mor, M
Rivara, S
Plazzi, PV
Nonno, R
Lucini, V
Pannacci, M
Fraschini, F
Stankov, BM
Citation: G. Spadoni et al., 2-N-acylaminoalkylindoles: Design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists, J MED CHEM, 44(18), 2001, pp. 2900-2912
Authors:
Pagani, G
Pregnolato, M
Ubiali, D
Terreni, M
Piersimoni, C
Scaglione, F
Fraschini, F
Gascon, AR
Munoz, JLP
Citation: G. Pagani et al., Synthesis and in vitro anti-Mycobacterium activity of N-alkyl-1,2-dihydro-2-thioxo-3-pyridinecarbothioamides. Preliminary toxicity and pharmacokinetic evaluation, J MED CHEM, 43(2), 2000, pp. 199-204
Authors:
Scaglione, F
Demartini, G
Dugnani, S
Fraschini, F
Citation: F. Scaglione et al., In vitro comparative dynamics of modified-release clarithromycin and of azithromycin, CHEMOTHERA, 46(5), 2000, pp. 342-352
Authors:
Scaglione, F
Demartini, G
Dugnani, S
Arcidiacono, MM
Pintucci, JP
Fraschini, F
Citation: F. Scaglione et al., Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin, BR J CL PH, 47(3), 1999, pp. 267-271
Authors:
Nonno, R
Pannacci, M
Lucini, V
Angeloni, D
Fraschini, F
Stankov, BM
Citation: R. Nonno et al., Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists, BR J PHARM, 127(5), 1999, pp. 1288-1294
Authors:
Spadoni, G
Balsamini, C
Bedini, A
Carey, A
Diamantini, G
Di Giacomo, B
Tontini, A
Tarzia, G
Nonno, R
Lucini, V
Pannacci, M
Stankov, BM
Fraschini, F
Citation: G. Spadoni et al., N-acyl-5- and -2,5-substituted tryptamines: Synthesis, activity and affinity for human mt(1) and MT2 melatonin receptors, MED CHEM RE, 8(9), 1998, pp. 487-498
Authors:
Leone, M
Lucini, V
D'Amico, D
Grazzi, L
Moschiano, F
Fraschini, F
Bussone, G
Citation: M. Leone et al., Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache, CEPHALALGIA, 18(10), 1998, pp. 664-667